These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2976867)

  • 1. [Pre-Sézary erythroderma developing into Sézary syndrome: apropos of 2 observations].
    Soria C; Ledo E; Sendagorta E; Ledo A; Rocamora A
    Med Cutan Ibero Lat Am; 1988; 16(5):403-6. PubMed ID: 2976867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-Sézary erythroderma evolving to Sézary syndrome. A report of seven cases.
    Buechner SA; Winkelmann RK
    Arch Dermatol; 1983 Apr; 119(4):285-91. PubMed ID: 6220677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.
    el-Azhary RA; Bouwhuis SA
    Int J Dermatol; 2005 Jan; 44(1):25-8. PubMed ID: 15663654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of pre-Sézary syndrome preceded by hand lesions.
    Lee NH; Lee SW; Choi EH; Lee WS; Ahn SK
    J Dermatol; 1999 Jul; 26(7):465-8. PubMed ID: 10458089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sézary cell count in exfoliative dermatitis.
    Duangurai K; Piamphongsant T; Himmungnan T
    Int J Dermatol; 1988 May; 27(4):248-52. PubMed ID: 2968960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hyperkeratotic and desquamative reaction in a patient with Sézary syndrome treated with bexarotene.
    Bagazgoitia L; Pérez-Carmona L; Ríos L; Muñoz E; Harto A; Jaén P
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):389-90. PubMed ID: 18269619
    [No Abstract]   [Full Text] [Related]  

  • 7. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Sézary syndrome--an erythrodermic T-cell-lymphoma].
    Haustein UF; Gast W; Schippel K; Schippel G; Rytter M
    Z Gesamte Inn Med; 1979 Jan; 34(2):72-8. PubMed ID: 154782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sézary syndrome without erythroderma.
    Henn A; Michel L; Fite C; Deschamps L; Ortonne N; Ingen-Housz-Oro S; Marinho E; Beylot-Barry M; Bagot M; Laroche L; Crickx B; Maubec E
    J Am Acad Dermatol; 2015 Jun; 72(6):1003-9.e1. PubMed ID: 25981000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic erythroderma: a follow-up study of 28 patients.
    Sigurdsson V; Toonstra J; van Vloten WA
    Dermatology; 1997; 194(2):98-101. PubMed ID: 9094454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sézary's syndrome (author's transl)].
    Guilhou JJ; Meynadier J; Clot J
    Nouv Presse Med; 1978 Jan; 7(1):29-34. PubMed ID: 149300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.
    Mangold AR; Thompson AK; Davis MD; Saulite I; Cozzio A; Guenova E; Hodak E; Amitay-Laish I; Pujol RM; Pittelkow MR; Gniadecki R
    J Am Acad Dermatol; 2017 Oct; 77(4):719-727. PubMed ID: 28709694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.
    Bouwhuis SA; el-Azhary RA; McEvoy MT; Gibson LE; Habermann TM; Witzig TE; Pittelkow MR
    Int J Dermatol; 2002 Jun; 41(6):352-6. PubMed ID: 12100691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
    Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
    Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-Sézary syndrome.
    Winkelmann RK; Buechner SA; Diaz-Perez JL
    J Am Acad Dermatol; 1984 Jun; 10(6):992-9. PubMed ID: 6234331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphocytochemical characteristics of Sézary cells in the erythrodermic form of mycosis fungoides and Sézary syndrome].
    Kozinets GI; Skripkin IuK; Lezvinskaia EM; Dul'tsina SM; Diagileva OA
    Sov Med; 1986; (4):43-7. PubMed ID: 2940703
    [No Abstract]   [Full Text] [Related]  

  • 17. Atopic dermatitis-like pre-Sézary syndrome: role of immunosuppression.
    Sokołowska-Wojdyło M; Barańska-Rybak W; Cegielska A; Trzeciak M; Lugowska-Umer H; Gniadecki R
    Acta Derm Venereol; 2011 Sep; 91(5):574-7. PubMed ID: 21681350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sézary syndrome].
    Betti R; Marchegiani G; Gagliardi P
    Minerva Med; 1982 Apr; 73(15):977-82. PubMed ID: 6210853
    [No Abstract]   [Full Text] [Related]  

  • 19. Sezary syndrome: diagnosis and management.
    Ogilvie C; Jackson R; Leach M; McKay P
    J R Coll Physicians Edinb; 2012; 42(4):317-21. PubMed ID: 23240118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified staging classification for cutaneous T-cell lymphoma.
    Kashani-Sabet M; McMillan A; Zackheim HS
    J Am Acad Dermatol; 2001 Nov; 45(5):700-6. PubMed ID: 11606919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.